Sentinel Lymph Node clinical trials at UC Irvine
1 research study open to eligible people
open to eligible females ages 18 years and up
Vulvar cancer patients with SN-metastasis > 2mm will receive chemoradiation instead of an inguinofemoral lymphadenectomy.
Orange, California and other locations
Our lead scientists for Sentinel Lymph Node research studies include Krishnansu Tewari.